Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Trends Pharmacol Sci. 2022 Apr 19;43(6):510–521. doi: 10.1016/j.tips.2022.03.003

Figure 2.

Figure 2.

The fundamental role of CMC in the in vivo efficacy and systemic toxicity of self-assembling prodrugs (SAPDs). Illustration of the circulation fate of a SAPD after entering into the circulation, indicates that the lower the CMC of a SP, the lower the percentage of fragments and monomers, leading to reduced excretion and enhanced tumor (improved efficacy) and healthy organ uptake (increased toxicity). Adapted from [38].